TECAR Therapy on Pain and Quality of Life in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

ConditionProstatitis

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexMale

Age30-50

SponsorMiddle East University

About this trial

Evaluate the effect of TECAR therapy on pain, voiding, erectile function, sleep quality and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome.

Eligibility criteria

Qualifiers

Presence of chronic prostatitis/chronic pelvic pain symptoms for more than 6 months.

Ages will be ranged from 30 to 50 years old.

Disqualifiers

Urinary and seminal infections.

Recent parenteral steroid administration.

Prior prostate or pelvic surgery.

Lower urinary tract disorders such as bladder stones.

Trial design

Treatments tested in this trial

TECAR therapy
Sham TECAR therapy

Treatment groups

60 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Middle East University

Lead sponsor

Source ClinicalTrials.gov